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Innate lymphoid cells (ILCs) reside at mucosal
surfaces and control immunity to intestinal infec-
tions. Type 2 innate lymphoid cells (ILC2s) produce
cytokines such as IL-5 and IL-13, are required for
immune defense against helminth infections, and
are involved in the pathogenesis of airway hyperre-
activity. Here, we have investigated the role of the
transcription factor GATA-3 for ILC2 differentiation
and maintenance. We showed that ILC2s and their
lineage-specified bone marrow precursors (ILC2Ps),
as identified here, were characterized by continuous
high expression of GATA-3. Analysis of mice with
temporary deletion of GATA-3 in all ILCs showed
that GATA-3 was required for the differentiation and
maintenance of ILC2s but not for RORgt+ ILCs.
Thus, our data demonstrate that GATA-3 is essential
for ILC2 fate decisions and reveal similarities
between the transcriptional programs controlling
ILC and T helper cell fates.
INTRODUCTION
Immunity to infections requires a highly coordinated response by
the innate and adaptive immune systems. In order to deal effi-
ciently with different types of pathogens, distinct effector pro-
grams are initiated. For example, intracellular infections lead to
the induction of a T helper (Th) cell response characterized by
the expression of IFN-g (i.e., Th1 cells). Immunity against worm
infections is, in part, coordinated by Th2 cells that release cyto-
kines such as IL-4, IL-5, and IL-13. Such diverse Th cell
responses are instructed by a distinct set of signals from the
innate immune system. Fate decisions of Th cells are controlled
by the induction of cell fate-determining transcription factors634 Immunity 37, 634–648, October 19, 2012 ª2012 Elsevier Inc.such as T-bet, GATA-binding protein 3 (GATA-3), or retinoic
acid receptor-related orphan receptor (ROR)gt for Th1, Th2, or
Th17 cells, respectively. Strikingly similar effector programs exist
within populations of innate lymphocytes.
A group of cells, widely referred to as innate lymphoid cells
(ILCs), has attracted particular attention recently (Spits and Di
Santo, 2011). They consist of RORgt-expressing lymphoid tissue
inducer (LTi) cells (also referred to as RORgt+ ILCs) and type 2
ILCs (ILC2s). In contrast to IL-22- and IL-17-producing RORgt+
ILCs, ILC2s can produce IL-5 and IL-13 and possibly also IL-4
(Saenz et al., 2010). Such an effector profile is reminiscent of
Th2 cells and this ILC subset is variably referred to as natural
helper cells (Moro et al., 2010), nuocytes (Neill et al., 2010),
ILC2s (Spits and Di Santo, 2011), or type 2 innate helper (Ih2)
cells (Price et al., 2010). We will refer to these cells as ILC2s.
Similar to the biological role of Th2 cells, ILC2s are involved in
the defense against worm infections (Liang et al., 2012; Moro
et al., 2010; Neill et al., 2010) and in tissue repair after influenza
virus infection (Monticelli et al., 2011). They also have a role in
autoimmunity, specifically the initiation of airway hyperreactivity
(Chang et al., 2011). The transcription factors determining ILC2
fate are currently not known and ILC2s are, therefore, defined
by (1) various cell surface markers (i.e., IL-7Ra, Sca1, Kit,
ICOS); (2) the expression of receptors for the cytokines IL-33
(ST1-T2) and IL-25 (IL-17RB); or (3) their production of the
‘‘type 2’’ cytokines IL-5 and IL-13. GATA-3 is a double zinc-finger
transcription factor that is required for the effector fate decision
of Th2 cells (Zheng and Flavell, 1997; Zhu et al., 2004). Various
reports have shown that ILC2s contain Gata-3 transcripts
(Moro et al., 2010; Price et al., 2010; Yang et al., 2011) and
GATA-3 was expressed by subsets of ILC2 after Nippostrongy-
lus (N.) brasiliensis infection, suggesting that GATA-3may be up-
regulated after infection (Liang et al., 2012). It remains a funda-
mental and unresolved issue as to whether GATA-3 is essential
for lineage commitment and/or differentiation of ILC2s, compa-
rable to the role of RORgt for the differentiation and function of
RORgt+ ILCs.
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GATA-3 and ILC2 FateAlthough RORgt+ ILCs and ILC2s have distinct functional
profiles, they share developmental requirements, indicating
developmental relationships. Both ILC subsets develop from
the common lymphoid progenitor (CLP) in a process that
requires Notch signaling (Possot et al., 2011; Wong et al.,
2012). Development of the two ILC lineages and of NK cells
but not of B or T cells requires the inhibitor of DNA binding 2
(Id2), suggesting that innate lymphocytes may have a common
Id2-dependent progenitor (Moro et al., 2010; Yokota et al.,
1999). Id2 is a helix-loop-helix (HLH) protein, which heterodi-
merizes with E proteins, that then can no longer initiate tran-
scription of target genes because their DNA binding is impaired
(Boos et al., 2007; Kee, 2009). Although the requirement of
Id2 for the development of innate lymphocytes is well recog-
nized, its expression by ILCs remains uncharacterized, as
does the precise stage during differentiation at which induction
occurs.
To assess the role of GATA-3 in the differentiation, maturation,
and function of ILC2s, we utilized Id2 and GATA-3 reporter mice
and also genetically modified mice, allowing for controlled
temporary deletion of Gata-3 in all innate lymphocyte subsets
and in T cells (Gata-3iDILC,T mice). Although all innate lympho-
cytes (i.e., RORgt+ ILCs, ILC2s, and NK cells) expressed high
amounts of Id2, high GATA-3 expression was an exclusive and
continuous attribute of all ILC2s. We also identified a GATA-3hi
population among lineage marker-negative (Lin) Sca1hiId2hi
cells in the bone marrow that we refer to as LinSca1hiId2hi
GATA-3hi (LSIG) cells. Transfer studies and clonal in vitro cultures
revealed that LSIG cells constitute a lineage-specified progenitor
tomature ILC2s that we have termed the ILC2 progenitor, ILC2P.
Genome-wide transcriptome profiling demonstrated that ILC2Ps
are highly related to ILC2s but lacked expression of maturation
markers such as the killer lectin-like receptor (KLR)G1 and of
type 2 cytokine genes (i.e., IL-5 and IL-13). Induced deletion of
GATA-3 in ILCs led to a selective loss of mature ILC2s, as well
as of the ILC2Ps in the bone marrow, whereas development of
the RORgt+ ILC lineage was not affected. These data demon-
strate that GATA-3 is required for the differentiation of ILC2Ps
and the maintenance of mature ILC2s. Our data establish
GATA-3 both as a transcription factor continuously expressed
by all ILC2s and as being essential for ILC2 fate decisions.
RESULTS
ILC2s Are GATA-3-Expressing Innate Lymphocytes
To date, ILC2s are defined by a combination of cell surface
markers (e.g., Sca1, CD25, and CD127) and their propensity to
produce IL-5 and IL-13. However, these cell surface markers
are nonspecific markers also expressed by other innate lympho-
cyte subsets (e.g., RORgt+ ILCs) and lymphoid precursors
(Buonocore et al., 2010; Sawa et al., 2010; Vonarbourg et al.,
2010). We tested our hypothesis that GATA-3 is the lineage-
defining transcription factor of ILC2s by examining GATA-3
expression by CD25+Sca1hi or CD127+Sca1hi cells among
CD3CD19 cells, marker combinations widely used to ‘‘define’’
ILC2s (Moro et al., 2010; Neill et al., 2010; Price et al., 2010;
Saenz et al., 2010). CD25+Sca1hi cells found in the lamina propria
of the small intestine were largely GATA-3 positive (79.6% ±
7.1%) (Figure 1A). The CD127+Sca1hi subset was less welldefined but still showed GATA-3 expression in more than 60%
of the population (64.8% ± 11.4%) (Figure 1A).
We next examined whether costaining with GATA-3 and Sca1
was sufficient to define ILC2s. Staining of leukocytes with anti-
bodies specific for GATA-3 and Sca1 revealed a well-defined
population of GATA-3hiSca1hi cells that was prominently repre-
sented in the lamina propria of small intestine and colon and,
to a lesser extent, the mesenteric lymph nodes (mLNs) and lungs
(Figures 1B and S1A and S1B available online). GATA-3hiSca1hi
cells in the CD3CD19 subset coexpressed all of the markers
normally associated with ILCs, such as CD25 (Figure 1B),
CD127, CD90 (Thy1), and Kit (Figure 1C). GATA-3hiSca1hi cells
also displayed more specific ILC2 markers, for instance, the
receptor for the cytokine IL-33 (T1-ST2) (Figure 1C). Importantly,
GATA-3hi ILCs did not express markers associated with either
the myeloid lineage or IL-33R-expressing granulocytes (FcεRI)
(Figure S1C). In addition, GATA-3hi ILCs were negative for
markers of RORgt+ ILCs such as CD4, RORgt, or CCR6, and
they did not express NK cell receptors (e.g., NKG2D or NK1.1)
or CD122 expressed by all NK cells (Figure S1D). We noticed
apopulation of Sca1int-hi innate (CD3CD19) lymphocytes in the
small intestine that expressed intermediate levels of GATA-3
(GATA-3int) (Figure S1E). Further characterization revealed that
the majority of these were RORgt or NKp46-expressing cells of
the NK and RORgt+ ILC lineage, respectively (Figure S1E).
Thus, the markers typically used to define ILC2s also define
GATA-3hi ILCs. The other innate lymphocyte lineages and
myeloid cells did not contain a GATA-3hi population.
ILC2s are functionally defined by their expression of IL-5 and
IL-13. We investigated whether GATA-3hi ILCs could also pro-
duce these cytokines. We used mice expressing green fluores-
cent protein (GFP) under the control of the Gata-3 promoter
(Grote et al., 2006). Direct comparison of GATA-3 reporter
expression and intracellular stainingwith aGATA-3-specific anti-
body revealed that the fluorescent reporter faithfully marked all
GATA-3+ cells (Figure S1F). GATA-3hi ILCs, but not GATA-3– or
GATA-3int innate lymphocytes, produced IL-5 and IL-13 after
incubation with phorbol 12-myristate 13-acetate (PMA) and
ionomycin (Figures 1D and 1E). Thus, IL-5 and IL-13 expression
by ILCs was strictly correlated with high GATA-3 expression. In
contrast, GATA-3int cells but not GATA-3hi cells released IL-22
and IFN-g, cytokines produced by RORgt+ ILCs and NK cells,
respectively (Figure 1D). These data further demonstrate that
GATA-3int cells also do not fulfill the functional criteria of ILC2s.
Further support for our hypothesis that ILC2s are GATA-3hi
ILCs arose from the analysis of their representation in various
gene-deficient mouse strains. Consistent with previous findings
regarding ILC2 development (Moro et al., 2010), GATA-3hi ILCs
were reduced in Il7r/ and Il7/ mice as well as in alymphoid
Rag2/Il2rg/ mice (Figures 1F and 1G). In contrast, mice
genetically lacking (1) recombination activating gene 2 (Rag2/
mice lacking B and T cell development); (2) IL-15 (Il15/ mice
lacking the NK cell lineage); (3) RORgt (Rorc(gt)/) or aryl hydro-
carbon receptor (Ahr/), both of which have reduced intestinal
RORgt+ ILCs; and (4) the thymic stromal lymphopoietin receptor
(Tslpr/) showed normal development and differentiation of
GATA-3hi ILCs (Figures 1F and1G). Collectively, our data demon-
strate that GATA-3-expressing ILCs are functionally, phenotypi-
cally, and developmentally identical to the ILC2 subset.Immunity 37, 634–648, October 19, 2012 ª2012 Elsevier Inc. 635
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Figure 1. ILC2 Cells Are GATA-3-Expressing Innate Lymphoid Cells
(A) Expression of GATA-3 by CD25+Sca1hi (top) or CD127+Sca1hi (bottom) lamina propria lymphocytes from the small intestine. Dot plots were gated on
CD45+CD3CD19 lymphocytes. Numbers represent percentages of cells in the indicated gates.
(B) Representative flow cytometry analyses of Sca1 and GATA-3 expression (top) by CD45+CD3CD19 lymphocytes from the indicated organs. Histograms
(bottom) represent staining with CD25 antibody (gray) or control Ig (open) by electronically gated GATA-3hiSca1hi cells. Numbers represent percentage of cells in
quadrant.
(C) Lamina propria lymphocytes from the small intestine were costained with CD3, CD19, Sca1, and GATA-3 antibodies and with antibodies specific for the
indicated markers (gray) or isotype control Ab (open). Histograms are electronically gated on Sca1hiGATA-3hi cells within the CD45+CD3CD19 population.
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Figure 2. GATA-3hi ILCs Express KLRG1
(A) Coexpression of KLRG1 and CD25 or CD25 and GATA-3 by electronically gated GATA-3hiSca1hi (top) or KLRG1hiSca1hi (bottom) CD45+CD3CD19 lamina
propria leukocytes. Numbers indicate percent of cells in the indicated regions.
(B) Flow cytometry analysis of KLRG1 coexpression with the indicated cell surface markers and transcription factors by CD45+CD3CD19 lamina propria
leukocytes. Numbers represent percentage of cells per quadrant.
(C and D) Intracellular cytokine staining of lamina propria lymphocytes after 4 hr stimulation with PMA and ionomycin.
(C) Dot plots are gated on CD45+CD3CD19CD90+ lymphocytes. Numbers represent percentage of cells per quadrant.
(D) Percentage (±SEM; n = 6) of cytokine-producing GATA-3hi ILCs with (black bars) and without (white bars) stimulation.
(E) Lamina propria cells from mice at the indicated age were analyzed for GATA-3 and RORgt expression (top). Dot plots are electronically gated on CD45+
CD3CD19CD127+ cells. Numbers represent percentage of cells per quadrant. Histograms represent expression of KLRG1 and integrin a4b7 by electronically
gated GATA-3hiRORgt cells.
All data shown are representative of at least three independent experiments.
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GATA-3 and ILC2 FateKLRG1 Is a Marker of Mature ILC2s
Upon screening a large panel of cell surface markers to identify
genes coexpressed by GATA-3hi ILCs, we found that KLRG1
was expressed by virtually all ILC2s in adult mice (Figures 2A
and 2B). This is consistent with previously published data
showing elevated KLRG1 mRNA expression in ILC2s (Neill
et al., 2010). Indeed, virtually all GATA-3hiSca1hi cells were
KLRG1 positive (Figure 2A, top) and all KLRG1hiSca1hi cells
were GATA-3hi ILCs (Figure 2A, bottom). In further support of
this view, IL-5 and IL-13 production was found only in KLRG1+
cells. KLRG1 cells were producers of IL-22 and IFN-g (Figures
2C and 2D). NKp46+ NK cells of the small intestine were found to
be KLRG1 negative (Figure 2B). This is consistent with our
previous data (Sanos et al., 2009) and in contrast to splenic NK
cells (Hanke et al., 1998). Thus, KLRG1 can be described as
a reasonably selective marker of mature intestinal ILC2s.
We observed that 10% of ILC2s were KLRG1 negative
(Figures 2A and 2B). KLRG1 has been recognized as a marker
of mature lymphocytes (Huntington et al., 2007; Voehringer
et al., 2001), prompting us to analyze KLRG1 expression by(D and E) Intracellular cytokine staining of lamina propria lymphocytes from Gata
(D) Dot plots are gated on CD3CD19CD45+CD90+ lymphocytes. Numbers rep
(E) Percentage (±SEM; n = 5) of cytokine-producing GATA-3hi ILCs with (black b
(F) Flow cytometry analysis of GATA-3 and Sca1 expression by CD45+CD3CD1
(G) Absolute cell numbers of GATA-3hiSca1hi ILCs (±SD; n = 4) in the lamina pro
Data are representative of at least three independent experiments. See also FiguILC2sduring ontogeny. AlthoughRORgt+ ILCswere substantially
represented among CD3CD19 cells in the intestinal lamina
propria of newborn mice, only a few GATA-3hi ILCs were present
(Figure 2E). However, their fraction steadily increased during
the first 2 months after birth (Figure 2E). Intriguingly, GATA-3hi
ILCs of newborn mice expressed substantial levels of integrin
a4b7, an integrin required for lymphocyte homing to and retention
in the intestine (Gorfu et al., 2009). Increasing age brought about
a steady decline in integrin a4b7 levels (Figure 2E). These findings
suggest a maturation program of ILC2s characterized by the
acquisition of KLRG1 and a loss of integrin a4b7.
Lin–Id2hi Bone Marrow Lymphocytes Coexpress High
Amounts of GATA-3 and Sca1
It has been reported that ILC2s are the progeny of bone marrow
CLPs (Wong et al., 2012; Yang et al., 2011). To obtain further
insights into the distinct stages of ILC2 differentiation, we
analyzed GATA-3 and Id2 expression by hematopoietic pre-
cursor cells (lineage marker-negative cells) in the bone marrow.
We chose to monitor Id2 in conjunction with GATA-3 for two-3Gfp/+ mice after 4 hr stimulation with PMA and ionomycin.
resent percentage of cells per quadrant.
ars) and without (white bars) stimulation.
9 cells from the intestinal lamina propria of the indicated mouse strains.
pria of the small intestine isolated from the indicated mouse strains.
re S1.
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Figure 3. Identification of GATA-3hi ILCs in the Bone Marrow
(A andB) Expression of Id2 (GFP) (gray) by the indicated cell subsets obtained from spleen or intestinal lamina propria of Id2Gfp/+mice. Open histograms represent
analysis of the same population from control mice (A). (B) Mean fluorescence intensity (MFI ± SEM; n = 4) of Id2 (GFP) expression in comparison to control mice by
the indicated cell subsets isolated from the intestinal lamina propria.
(C) Id2 (GFP) and GATA-3 (GFP) expression (gray) by the indicated bone marrow cell populations (HSC/MPP: LinCD127Sca1+Kit+; CLP: LinCD127+
CD135+Sca1loKitlo). Open histograms represent analysis of the same population from control mice. Numbers indicate percentage of positive cells.
(D) Analyses of Sca1, Id2 (GFP), and GATA-3 expression by Lin cells. The dot plots to the right show CD127 and CD25 expression by electronically gated
Sca1hiId2hi (top) or Sca1hiGATA-3hi (bottom) cells. Numbers represent percentage of cells in the indicated gates.
(E) Flow cytometry analysis of CD44 and CD90 expression (gray) by bone marrow LSI cells. Open histograms show staining with an isotype-matched control
antibody.
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GATA-3 and ILC2 Fatereasons: (1) a precursor to the lineage of ILC2 may not yet
express GATA-3 and (2) Id2 is required for the development of
all innate lymphocytes (Moro et al., 2010; Yokota et al., 1999).
Although the role of Id2 in innate lymphocyte development is
well established, its expression pattern lacks definition. We
have studied Id2 expression in Id2Gfp/+ mice, a genetically modi-
fied mouse strain that expresses a fluorescent reporter (GFP)
under the control of the Id2 promoter to allow faithful tracking
of Id2-expressing cells (Rawlins et al., 2009). Utilizing these
mice, we discovered that all mature innate lymphocyte lineages
(NK cells, ILC2s, and NKR+ and NKR RORgt+ ILCs) were Id2hi
(Figures 3A and 3B). Thymic CD4CD8 (double-negative, DN)
T cells and CD4+CD8+ (i.e., DP) T cells were negative for Id2,
whereas CD4+CD8 or CD4CD8+ (i.e., SP) T cells expressed
low amounts of Id2 (Figure S2A), which was maintained in
peripheral T cells (Figure 3A). As previously reported (Jackson
et al., 2011), B cells (Figure 3A) and most mononuclear phago-
cytes (Figure S2B) did not express appreciable amounts of Id2.
CD11c+ DCs were Id2lo (Figure S2B), a finding consistent with
a role of Id2 for the development of DC subsets (Hacker et al.,
2003; Jackson et al., 2011). Thus, under steady-state conditions,
high Id2 expression is a specific characteristic of all innate
lymphocytes.
Among Lin-negative hematopoietic precursors in the bone
marrow, Id2 is not expressed by hematopoietic stem cells
(HSCs) and multipotent progenitors (MPPs) or common lym-
phoid progenitors (CLPs) (Figure 3C). We detected a substantial
population of Lin-negative cells that uniformly coexpressed Id2
and Sca1 (Figure 3D). These LinSca1hiId2hi (LSI) cells also
homogenously expressed CD127 and CD25 (Figure 3D) together
with CD44 and CD90 (Figure 3E), markers that are characteristic
of ILCs. Conversely, LinSca1hiCD127+CD25+ cells were uni-
formly Id2 positive (Figure 3C). These cells also, unexpectedly,
showed a uniformly high expression of GATA-3 (Figures 3C
and 3D). The population of LSI cells was virtually identical to
LinSca1hiGATA-3hi cells (Figures 3C and 3D) and we will, there-
fore, refer to these as LinSca1hiId2hiGATA-3hi (LSIG) cells. LSIG
cells were developmentally dependent on Il2rg, Id2, and Il7r but
were independent of Rag2, Rorc(gt), Il15, and Tslpr gene ex-
pression (Figure 3F), a developmental program reminiscent of
intestinal ILC2s (Figure 1F).
Genome-wide Expression Profiling of LSIG Cells
Reveals Close Relationship to ILC2s
LSIG cells may be multipotent progenitors to various innate
lymphocyte lineages or may constitute lineage-specified pro-
genitors to ILC2s. We analyzed expression of cell surface
markers and the functional profile of LSIG cells. LSIG cells did
not express markers associated with the NK cell lineage (Fig-
ure S3A), the RORgt+ ILC fate (Figures S3B and S3C), the
myeloid lineage (Figure S3D), or multipotent hematopoietic
progenitors (Figure S3E). In addition to Id2 and GATA-3, these
cells expressed a number of markers also found onmature intes-
tinal ILC2s, including receptors for the cytokines IL-33 (T1-ST2)(F) The indicatedmouse strains were analyzed for the presence of bonemarrow Lin
gates.
Data are representative of at least three independent experiments. **p %
Figure S2.and IL-25 (IL-17RB) (Figures 4A and 4B). Other innate lympho-
cyte populations do not express these receptors, which provides
support for the lineage-specified progenitor model. However,
there were also conspicuous differences compared to mature
ILC2s. Bone marrow LSIG cells lacked expression of KLRG1
and Kit (Figures 4A and 4B). Similar to the immature KLRG1
GATA-3hi ILCs found in newborn mice (Figure 2E), a subset of
LSIG cells expressed integrin a4b7 (Figure 4A), which was absent
from mature KLRG1+ ILC2s (Figure 2E). Direct comparison of
the functional profile of LSIG cells to that of mature ILC2s via
qRT-PCR revealed that Il4, Il5, and Il13 but not Il22, Il17a, or
Ifng were highly expressed in mature ILC2s (Figure 4C, black
bars), whereas expression was low in LSIG cells (Figure 4C,
open bars). To confirm these findings, we directly compared
IL-5 production by LSIG cells and mature intestinal ILC2s
in vitro. Although intestinal ILC2s were potent producers of
IL-5, bone marrow LSIG cells produced only very low amounts
(Figure 4D).
We performed genome-wide transcriptome analysis of highly
purified LSIG cells, intestinal ILC2s, and NKR+ or NKR RORgt+
ILCs to better assess the similarities and discrepancies of gene
expression among these different ILC populations. The hierar-
chical clustering analysis of the four ILC subsets generated
two distinct cell clusters: the first cluster grouped together
NKR and NKR+ RORgt+ ILCs, as already revealed by previous
data (Reynders et al., 2011), and the second cluster combined
LSIG cells and mature ILC2s (Figure 4E). These data demon-
strate a profound relationship between the transcriptional
programs of the GATA-3hi ILC subsets in the intestine and the
bone marrow, whereas the profiles of the RORgt+ ILC subsets
were quite distant. We clustered and annotated selected genes
that showed the most robust and consistent differences in
expression (at least 2-fold) among the various ILC subsets (Fig-
ure 4F). A group of genes was found to be common to LSIG cells
and mature ILC2s, but not the RORgt+ ILC subsets (cluster 8,
ILC2-LSIG core cluster). Among them were the genes encoding
GATA-3, CD27, and Sca1 (Ly6A) and receptors of IL-33, IL-25,
and IL-9 (Figure 4G, top). Importantly, we could identify clusters
of genes differentially expressed by LSIG cells andmature ILC2s
(Figure 4G, bottom). Of note, the ILC2 signature cytokine genes
IL-5 and IL-13, as well as the gene for KLRG1, were strongly rep-
resented in intestinal ILC2s but not in bone marrow LSIG cells
(Figure 4G), a finding that concurred with the results described
above (Figures 4A–4D).
LSIG Cells Are Lineage-Specified Progenitors to ILC2s
Collectively, our findings from functional and genome-wide tran-
scriptional analyses demonstrate that LSIG cells and intestinal
ILC2s are highly related, albeit with differential expression of
gene clusters between the two ILC subsets. Thus, we propose
that LSIG cells are the lineage-specified progenitors of ILC2s.
We tested this model by examining the developmental potential
of LSIG cells in vitro and in vivo. We cultured highly purified LSIG
cells on mitotically inactivated OP9 feeder cells or Notch ligandSca1hiGATA-3hi cells. Numbers represent percentage of cells in the indicated
0.01, ***p % 0.001. LSI: LinSca1hiId2hi bone marrow cells. See also
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Figure 4. Transcriptome Analysis Reveals Close Relationship between LSIG Cells and ILC2s
(A) Flow cytometry analysis of the indicated cell surfacemarkers (gray) by bonemarrow LSIG cells. Open histograms depict staining with isotype-matched control
antibodies.
(B and C) Quantitative RT-PCR analysis (±SEM; n = 3) of expression of the indicated genes by LSIG cells (white bars) or ILC2s (black bars).
(D) Percentage (±SEM; n = 4) of IL-5-producing bone marrow LSIG cells (white bars) compared to ILC2s from the small intestine (black bars).
(E) Hierarchical clustering of normalized microarray data of replicate RNA samples from the indicated cell subsets. Dendrogram was obtained by analyzing 911
out of 28,441 probe sets.
(F) Heat map representation of genes clustering with at least 2-fold differences in expression pattern across different cell subsets as assessed by k-means.
Columns represent the indicated cell subsets in four or five biological replicates. Each row represents one examined gene. Hierarchical clustering revealed ten
different clusters as indicated. The color code at the bottom defines the expression intensity of each individual gene in all examined cell subsets.
(G) Functional classification of the gene profiles shared by LSIG and ILC2s (i.e., ILC2/LSIG core cluster) and specific for ILC2s as assessed by k-means.
Representative genes within these clusters are indicated. Signature gene expression profiles of the respective clusters used in the functional annotation are
indicated above.
Data are representative of three independent experiments. **p% 0.01. LSIG: LinSca1hiId2hiGATA-3hi bone marrow cells. See also Figure S3.
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GATA-3 and ILC2 Fatedelta-like 1 (Dll1)-expressing OP9 cells, which is required to
generate T cells from uncommitted precursor cells (Schmitt
and Zu´n˜iga-Pflu¨cker, 2002). When cultured on OP9 or OP9-
Dll1 cells in the presence of IL-7 or IL-7 plus IL-33, LSIG cells
did not show any appreciable T or B cell potential (Figure S4A)
but, instead, remained uniformly Id2- and GATA-3-expressing
cells (Figures 5A and 5B). We were also unable to find any
evidence of innate multilineage potential in LSIG cells. When
cultured in the presence of cytokines permissive for NK cell dif-
ferentiation, LSIG cells showed no signs of NK cell differentiation
such as upregulation of NKR (Figure 5A). In addition, LSIG cells
cultured in the presence of cytokines promoting differentiation
of RORgt+ ILCs (IL-1b, IL-23, IL-2, and IL-7) did not upregulate
expression of IL-17A, IL-22, IL-23R, or RORgt, indicative of the
RORgt+ ILC fate (Figures 5C and S4B). Interestingly, bone
marrow LSIG cells, which are KLRG1 negative, upregulated
KLRG1 expression when cultured in medium containing IL-7640 Immunity 37, 634–648, October 19, 2012 ª2012 Elsevier Inc.and IL-2, in particular if IL-33 (Figures 5B and 5D) or IL-25 (Fig-
ure 5D) were present. In contrast, culture of LSIG cells in the
presence of thymic stromal lymphopoietin (TSLP) did not lead
to the upregulation of KLRG1 (Figure 5D). Clonal differentiation
assays confirmed that LSIG cells remained stably GATA-3-
and Id2-expressing ILCs (Figure S4C). In addition, a fraction of
clones upregulated KLRG1 (Figure S4D).
To further test our theory that LSIG cells differentiate into
ILC2s, we assessed cytokine production after in vitro differenti-
ation. Culture of LSIG cells with IL-7 and SCF, conditions in
which they do not substantially expand (Figure S4E), led to
low-level production of IL-5 and IL-13 (Figures 5E and 5F and
data not shown), similar to that observed in in vivo nondifferenti-
ated bone marrow LSIG cells (Figures 4C and 4D). TSLP did not
show any significant effect on the maturation (Figure 5D) or cyto-
kine production (Figure 5F) of LSIG cells in vitro. In contrast, LSIG
cells differentiating in the presence of IL-33 or IL-25 became
Immunity
GATA-3 and ILC2 Fatepotent producers of IL-5 and IL-13, indicative of differentiation
into ILC2s (Figures 5E and 5F). However, cytokines such as
IFN-g or IL-22, which are associated with different innate
lymphocyte fates, could not be detected (Figures 5C and 5E).
Collectively, these data demonstrate that LSIG cells exclusively
differentiate into the IL-5- and IL-13-producing KLRG1+ ILC2
subset.
To provide additional support for our hypothesis that LSIG
cells are the lineage-specified precursors of ILC2s, we trans-
ferred highly purified LSIG cells (H-2b) into alymphoid
Rag2/Il2rg/ mice (H-2d) and tracked their differentiation
potential. After transfer, donor-derived cells were found in
organs in which ILC2s reside (e.g., intestine) (Figures 5G, S4F,
and S4G) but not in lungs, liver, or spleen (Figures S4F and
S4G). We tested whether injection of inflammatory cytokines
such as IL-25 and IL-33 led to recruitment of LSIG-derived
ILC2s to extraintestinal sites. Interestingly, 4 days after cytokine
injection, a small but reproducible population of LSIG-derived
cells was found in lungs, liver, and spleen (Figure S4G). Whereas
KLRG1 LSIG cells had no T cell, B cell, NK cell, or RORgt+ ILC
potential, donor-derived cells maintained expression of Id2 and
GATA-3. Intriguingly, virtually all precursor cells differentiated
into KLRG1+ ILC2s (Figure 5G), collectively demonstrating that
KLRG1 LSIG cells are precursors to mature intestinal KLRG1+
ILC2s. To obtain further evidence that KLRG1 LSIG cells
have precursor potential and do not simply constitute mature
ILC2s lacking KLRG1 expression (Brickshawana et al., 2011),
we directly compared the reconstitution efficiency of bone
marrow-derived KLRG1 LSIG cells to that of mature small intes-
tinal KLRG1+ ILC2s upon transfer into alymphoid mice. The pop-
ulation of mature KLRG1+ ILC2s recovered from alymphoid mice
was approximately the same size as that injected. In contrast,
the KLRG1 LSIG population generated 20- to 30-fold more
progeny (Figures 5H and 5I), indicating that they had proliferated
after transfer to produce mature KLRG1+ ILC2s. From now on,
we will refer to the bone marrow KLRG1 LSIG population as
lineage-specified precursors to ILC2s (i.e., ILC2Ps).
It was recently reported that mice genetically lacking Rora
(encoding RORa) have reduced numbers of ILC2s after injec-
tions of IL-25 and that in vitro generation of ILC2s from Rora-
deficient CLP was impaired (Wong et al., 2012). However, it
remained unknown at which stage RORa is upregulated and
whether RORa expression or the effects of its deletion are
specific to ILC2s. We analyzed Rora expression by hematopoi-
etic progenitors, ILC2Ps, and mature ILC subsets by using
qRT-PCR. Although HSCs-MPPs and CLPs did not express
detectable levels of Rora, all mature innate lymphocyte subsets
showed robust expression of the Rora gene. ILC2Ps reproduc-
ibly contained lower but considerable numbers of Rora tran-
scripts, indicating that upregulation of RORa occurs in two
waves, during lineage specification of ILCs and at the transition
from ILC2Ps to mature ILC2s (Figure 5J).
ILC2Ps Develop into Functional ILC2s Conferring
Immunity to Helminth Infection
It has been recently demonstrated that ILC2s play an important
role in the clearance and prevention of infections with the
helminth parasite N. brasiliensis (Liang et al., 2012; Neill et al.,
2010). Alymphoid Rag2/Il2rg/ cannot control N. brasiliensisinfection (Figure 6A; Moro et al., 2010; Price et al., 2010).
However, adoptive transfer of ILC2Ps prior to worm challenge
led to a control of infection comparable to that in lymphoreplete
mice (Figure 6A). Donor-derived ILC2swere found in the intestine
and only very few cells homed to lungs and spleen prior to infec-
tion (Figure 6B). Interestingly, infection ofmicewithN. brasiliensis
led to a significant increase of ILC2P-derived ILC2s in small
intestine but also in lungs and spleen. Although eosinophils
were not recruited to the lungs of alymphoid mice, probably
because of the lack of an innate source of IL-5 and/or IL-13 (Liang
et al., 2012), mice receiving ILC2Ps prior to worm challenge
showed a profound accumulation of eosinophils in the lungs at
day 5 postinfection (Figures 6C and 6D). In the intestine, IL-13
expression has been shown to lead to increased differentiation
of mucin-producing goblet cells and to increased angiogenin
expression by Paneth cells supporting a milieu conducive
for worm expulsion (Steenwinckel et al., 2009). Although
N. brasiliensis-infected Rag2/Il2rg/ mice showed low-level
expression of angiogenin 4 or mucin 2, transfer of ILC2Ps led
to a substantial increase in the expression of these genes
(Figures 6E and 6F). Only few mucus-producing (i.e., Alcian
blue-positive) cells were found in the colon of N. brasiliensis-
infected Rag2/Il2rg/ mice. Transfer of ILC2Ps into alym-
phoid mice and consecutive infection led to goblet cell hyper-
plasia surpassing that of control mice (Figure 6G). Collectively
our data demonstrate that ILC2Ps can differentiate into func-
tional ILC2s, conferring protection against murine helminth
infection by inducing epithelial expression of the genes involved
in the defense against worms.
CCR9 Signals Are Required for the Migration of ILC2Ps
to the Intestine
We investigated the molecular signals involved in coordinating
the migration of ILC2s to the intestine. Our phenotypical charac-
terization of ILC2Ps and mature ILC2s revealed that both popu-
lations expressed high levels of the chemokine receptor CCR9
(Figure 6H), a chemokine receptor with essential function in the
homing of lymphocytes from bone marrow to the lamina propria
(Zabel et al., 1999). Ccr9 deficiency led to a significant decrease
of ILC2s in the intestinal lamina propria. However,Ccr9/ ILC2s
were not significantly diverted to extraintestinal organs, although
we consistently observed a larger fraction of ILC2s in bone
marrow, lungs, and mesenteric lymph nodes (Figures 6I and
6J). Collectively, our findings illustrate that migration of ILC2Ps
to the intestine is in part dependent on CCR9-mediated signals.
GATA-3 Is Required for ILC2 Cell Fate Decisions and
Maintenance of Mature ILC2s
Our data demonstrate that GATA-3 is a transcription factor
stably and continuously expressed by ILC2s and by ILC2Ps, their
lineage-specified bone marrow precursors. However, it remains
unknownwhether GATA-3 is required for their development and/
or differentiation. We developed a genetic model in which the
Gata-3 gene can be inducibly ablated in all ILCs (Figure S5A).
We crossed Id2CreERt2/+ mice (Rawlins et al., 2009) to mice
carrying a conditional Gata-3 allele (Gata-3f/f) (Grote et al.,
2008). Tamoxifen application induces nuclear translocation of
Cre allowing for the inducible inactivation of Gata-3. To faithfully
monitor Cre activity, we further crossed these mice to a strainImmunity 37, 634–648, October 19, 2012 ª2012 Elsevier Inc. 641
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Figure 5. LSIG Cells Are Lineage-Specified Progenitors of ILC2s
(A) Highly purified LSIG cells from Gata-3Gfp/+ mice or Id2Gfp/+ mice cells were cultured for 6 days on OP9 feeder cells in medium containing IL-7 and IL-15 and
tested for the expression of NKp46 and GATA-3 (left) or NK1.1 and Id2 (right). Numbers represent percentage of cells in quadrant.
(B) Highly purified LSIG cells were cultured on OP9 feeder cells in the presence of the indicated cytokines. KLRG1 and GATA-3 expression were determined after
7 days of culture. Numbers represent percentage of cells in quadrant.
(C) Quantitative RT-PCR analysis of expression of the indicated genes by ILC2s (black bars), by LSIG cells cultured for 7 days with cytokines favoring differ-
entiation of RORgt+ ILCs (IL-2, IL-7, IL-23, IL-1b) (white bars), or by RORgt+ ILCs (gray bars).
(D) Percentage (±SD; n = 3) of KLRG1+ cells after 7 day culture of purified LSIG cells on OP9 feeder cells in the presence of the indicated cytokines.
(E) Highly purified LSIG cells were cultured on OP9 feeder cells in the presence of the indicated cytokines. After 11 days of culture, IL-5 and IFN-g production was
determined by intracellular cytokine staining. Numbers represent percentage of cells per quadrant.
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GATA-3 and ILC2 Fatecarrying a fluorescent reporter (yellow fluorescent protein, YFP),
which comes under the transcriptional control of the ubiquitous
Rosa26 promoter once a transcriptional roadblock is excised by
Cre-mediated recombination (Figure S5A; Srinivas et al., 2001).
Id2 is highly expressed in ILC2Ps, innate lymphocytes, and
during T cell differentiation in the thymus (Figures 3A, 3C, and
S2A), so this approach produced mice in which the Gata-3
gene can be inducibly deleted in all innate lymphocyte lineages
and T cells (Gata-3iDILC,T). Cre activity correlated with Id2 expres-
sion so that Id2hi cells (e.g., ILC2s, ILC2Ps, RORgt+ ILCs) had
higher Cre activity than Id2lo cells (e.g., T cells) (Figure S5B).
Development of GATA-3intRORgt+ ILCs (Figure S1E) was unaf-
fected by the deletion of GATA-3 (Figure 7A), which allowed us
to investigate the efficiency of GATA-3 inactivation in the YFP+
(Cre-on) subset of RORgt+ ILCs. Upon induction of Cre expres-
sion by tamoxifen, GATA-3 expression was abolished in YFP+
RORgt+ ILCs (Figure 7B). Thus, Gata-3iDILC,T mice allow for effi-
cient inducible deletion of Gata-3 in innate lymphocytes.
We next treated Gata-3iDILC,T mice for 3 weeks with a tamox-
ifen-containing diet and analyzed ILC2s in the intestinal lamina
propria. Although the pool of RORgt+ ILCs was unaffected by
Gata-3 deficiency (Figures 7A and 7B), KLRG1+GATA-3hi cells
or RORgtKLRG1+ cells (both representing ILC2s) were virtually
absent in the GATA-3-deficient (i.e., YFP+) subset (Figures 7A
and 7C). This was also reflected in our analysis of the proportion
of KLRG1+ cells within all innate lymphocytes with Gata-3 dele-
tion (YFP+) (Figure 7D). In contrast, ILC2s were normally repre-
sented in the YFP-negative (Cre-off) subset spared from Cre-
mediated inactivation of Gata-3 (Figures 7A and 7C). Whereas
ILC2s are entirely lost in mice with conditional deletion of
Gata-3, the total pool of ILCs with Gata-3 deletion (YFP+) was
onlymildly reduced (Figure 7E), which reflects the normalmainte-
nance of RORgt+ ILCs and of additional ILC subsets in the
absence of GATA-3. It is unlikely that KLRG1, CD25, and Sca1
are under the direct transcriptional control of GATA-3, meaning
that a deficiency inGATA-3 is unlikely to have the knock-on effect
of obscuring detection of these markers. In support of this,
ILC2Ps do not express KLRG1 despite high GATA-3 expression
(Figures 3C, 3D, and Figures 4A). Nevertheless, we interrogated
cytokine production by CD3CD19 cells in order to visualize
residual innate type 2 cytokine producers in the absence of
GATA-3. Whereas the GATA-3-proficient (YFP) fraction of
innate lymphocytes produced IL-5 and IL-13 after stimulation
comparable to control mice, no cytokine producers were de-
tected in the GATA-3-deficient (YFP+) population (Figure 7F).
The entire intestinal pool of ILC2s was lost within few weeks of
Gata-3 inactivation (Figures 7A, 7C, and 7D). Maintenance of the
pool size of intestinal lymphocytes is the aggregate of two
parameters; cell half-life and the rate of replacement by newly(F) Percentage (±SD; n = 3) of IL5+ cells after 7 day culture of purified LSIG cells
(G) Highly purified bone marrow LSIG cells from Id2Gfp/+ mice (H-2b) were adop
transfer, donor-derived cells from the intestinal lamina propria were analyzed for t
in the indicated gates.
(H and I) The indicated numbers of highly purified bone marrow LSIG cells (H-2b
Il2rg/ hosts (H-2d). Four months after transfer, the fraction of donor-derived KLR
repopulation efficiency, the ratio (±SEM, n = 3) of LSIG cell-derived to ILC2-deriv
(J) Quantitative RT-PCR analysis of Rora expression by the indicated cell subset
All experiments are representative of at least two independent experiments. LSIGarriving progenitors. Therefore, our data have two important
implications. First, that mature ILC2s cannot be maintained
when Gata-3 is ablated and, second, that bone marrow-derived
ILC2Ps do not efficiently replenish the peripheral pool of KLRG1+
ILC2s when GATA-3 is inactivated. Because we could detect
ILC2s more than 4 months after transfer (Figures 5G and 5I),
our data do not favor the view that the absence of ILC2s
3–4 weeks after Gata-3 inactivation reflects the natural half-life
of this subset. To more directly address this issue, we cultured
highly purified YFP (i.e., Cre-off) KLRG1+ ILC2s from the lamina
propria of Gata-3f/f mice and of control mice in the presence of
tamoxifen for 7 days. Roughly 20% of ILC2s from Gata-3+/+
controls switched on Cre expression (i.e., became YFP positive)
during the 7 days of culture (Figure 7G). Interestingly, when Cre
activity was induced in ILC2s fromGata-3f/f mice, only very few if
any YFP+ cells could be found whereas the YFP (Gata-3-profi-
cient) ILC2s were normally maintained (Figure 7G). These data
establish that GATA-3 is required for the maintenance of mature
ILC2s.
Given the failure of ILC2Ps to repopulate the peripheral pool of
KLRG1+ ILC2s when Gata-3 is inactivated, we investigated the
role of GATA-3 in the development or maintenance of bone
marrow ILC2Ps. After inducible deletion of Gata-3, LSI cells
(i.e., ILC2Ps) were 6- to 10-fold reduced (Figure 7H). The re-
maining cells phenotypically resembled ILC2Ps in that they ex-
pressed high levels of Sca1 and CD25 (Figure 7I). It was
remarkable to find such a population of LinCD25+Sca1hi
bone marrow cells within the YFP+ (Cre-on) population (Fig-
ure 7I, bottom), and we suspected that they represented either
precursor cells that could not differentiate in the absence of
GATA-3 or remaining ILC2Ps. Culture of YFP+ (i.e., Cre-on)
LinCD25+Sca1hi cells from GATA-3-proficient control mice
led to the generation of KLRG1+ ILC2s (Figure 7J) as observed
before (Figure 5B). In contrast, culture of equal numbers of the
same subset isolated from Gata-3-deficient mice did not
generate any progeny (Figure 7J). Collectively, our data provide
evidence for a dominant role for GATA-3 at two central check-
points of the ILC2 lineage. First, GATA-3 is required for the
maintenance of mature ILC2s and of ILC2Ps. Second,
GATA-3 is an important factor in the maturation of ILC2Ps.
Thus, similar to the role of RORgt in RORgt+ ILCs, GATA-3 is
an essential determinant of ILC2 fate.
DISCUSSION
By using genetically modified mice to allow faithful tracking
of GATA-3-expressing cells and intracellular staining for this
transcription factor, we demonstrated that ILC2s are, by any
definition (phenotypic, functional, and developmental), GATA-3hion OP9 feeder cells in the presence of the indicated cytokines.
tively transferred into irradiated Rag2/Il2rg/ hosts (H-2d). Six weeks after
he expression of the indicated markers. Numbers represent percentage of cells
) or intestinal ILC2s (H-2b) were adoptively transferred into irradiated Rag2/
G1+ ILC2s among lamina propria leukocytes was determined. As ameasure of
ed KLRG1+ cells was determined (H).
s from bone marrow or the small intestine.
: LinSca1hiId2hiGATA-3hi bone marrow cells. See also Figure S4.
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Figure 6. Transfer of LSIG Cells Confers Immunity to N. brasiliensis Infection
(A–G) Highly purified LSIG cells were transferred into groups of Rag2/Il2rg/ hosts. Four weeks after transfer, the indicated groups of mice (n = 4–5) were
infected with N. brasiliensis and analyzed on day 5 of infection.
Immunity
GATA-3 and ILC2 Fate
644 Immunity 37, 634–648, October 19, 2012 ª2012 Elsevier Inc.
Immunity
GATA-3 and ILC2 FateILCs. Given that other innate lymphocyte lineages (i.e., RORgt+
ILCs and NK cells) expressed only low amounts of GATA-3,
high GATA-3 expression can be said to be a specific character-
istic of ILC2s. The presence of Gata-3 transcripts in ILC2s has
previously been reported (Moro et al., 2010; Price et al., 2010;
Yang et al., 2011). One recent report drew an interesting parallel
to Th2 cells by showing that a subset of lung-resident ILC2s (i.e.,
CD4CD8CD19ICOS+ cells) isolated from N. brasiliensis-
infected mice expressed GATA-3 (Liang et al., 2012). Our data
now demonstrate that all ILC2s constitutively express high
amounts of GATA-3.
We observed only a very small fraction of ILC2s in the intestine
of newborn mice. However, their proportion steadily increased
during the first 2 months after birth, indicating that ILC2s popu-
late the intestine in substantial numbers only postnatally. Pheno-
typical profiling showed that >90% of ILC2s of adult mice
expressed the lectin-like receptor KLRG1, which was absent
from GATA-3hi ILCs of newborn mice. Thus, we propose that
KLRG1 acts as a marker of mature ILC2s. KLRG1 is expressed
by a subset of mature splenic NK cells and by subsets of acti-
vated CD8+ T cells and its ligation can inhibit effector functions
in these lymphocyte subsets (Blaser et al., 1998; Hanke et al.,
1998; Huntington et al., 2007; Sarkar et al., 2008). KLRG1 is an
inhibitory immunoreceptor that binds to classical cadherins
(e.g., E-cadherin) (Gru¨ndemann et al., 2006; Ito et al., 2006),
highly expressed by intestinal epithelial cells. It is tempting to
speculate that the interaction of KLRG1 with E-cadherins may
dampen the function of ILC2s.
Previous data have indicated that ILC2s develop from CLPs
and are part of the lymphoid lineage (Wong et al., 2012; Yang
et al., 2011). However, the distinct stages of ILC2 development
or differentiation have not yet been recognized. Id2 is a transcrip-
tion factor required for the development of all innate lymphocyte
lineages (Moro et al., 2010; Yokota et al., 1999). We identified
a distinct population of Lin-negative Id2hi cells in the bone
marrow that coexpressed Sca1, CD25, CD127, and receptors
for IL-33 and IL-25. Phenotypic and genome-wide transcriptome
analysis of these LinSca1hiId2hi (LSI) cells revealed that they
were very closely related to ILC2s and only distantly related to
other innate lymphocyte lineages such as RORgt+ ILCs. LSIG
cells are lineage-specified precursors to mature KLRG1+ ILC2s
that we propose to refer to as ILC2Ps. Previous reports had
already indicated the presence of ILC2-like cells in the bone
marrow but failed to probe the developmental potential of these
cells (Brickshawana et al., 2011; Price et al., 2010). Importantly,(A) Total intestinal helminth counts.
(B) Percentage (±SD; n = 3) of donor-derived (CD45.1+) ILC2s in the indicated orga
(C) Representative dot plot of eosinophil (CD49bloSiglec-F+) accumulation in the lu
cells in the indicated gates.
(D) Percentage (±SEM; n = 4) of CD49bloSiglec-F+ cells.
(E and F) Quantitative RT-PCR analysis (±SD; n = 4) ofAngiogenin4 (E) andMucin2
groups.
(G) Alcian blue staining of cryosections of the small intestine. Arrowheads indica
100 mm. Original magnification, 320.
(H) CCR9 (GFP) expression by intestinal ILC2s and bone marrow ILC2Ps. Histogra
analysis of the same population from control mice.
(I and J) Representation of GATA-3hi ILCs (i.e., ILC2s or ILC2Ps) in C57BL/6 (I, top
the indicated gates. (J) Percentage (±SEM; n = 3) of GATA-3hi ILCs in the indicat
All data are representative of three or more independent experiments. *p% 0.05CD25+LinSca1+Kit (CD25+LSK) cells that are virtually iden-
tical to the LSIG population were recognizedmore than a decade
ago and considered perplexing because, after adoptive transfer,
and despite expression of ‘‘stem cell antigen,’’ they did not
generate any appreciable progeny in secondary lymphoid
organs (Kumar et al., 2008; Randall and Weissman, 1998).
Indeed, LSIG cells failed to home to secondary lymphoid organs
but were precursors to mature intestinal ILC2s.
GATA-3was required for themaintenance ofmature ILC2s and
bone marrow-resident ILC2Ps. It remains formally possible that
ILC2Ps cannot migrate to the intestinal mucosa in the absence
of GATA-3. This is another striking parallel to the role of
GATA-3 in Th2 cells, as they also require continuous GATA-3 ex-
pression for their maintenance (Pai et al., 2003; Zhu et al., 2004).
Interestingly, a subset ofGATA-3-negative LSI cellswere found in
the bone marrow of GATA-3-deficient mice. These cells under-
went in vitro differentiation into ILC2s only in the presence of
GATA-3, demonstrating that GATA-3 controls lineage specifica-
tion in this innate lymphocyte lineage. A recent report indicated
that RORa was required for efficient ILC2 development but the
precise stage of differentiation at which it acted was not exam-
ined (Wong et al., 2012). We have now shown that, in contrast
to GATA-3, RORa expression is not specific to the ILC2 lineage
but it is expressed at high levels by all innate lymphocytes.
RORa expression is probably upregulated in two waves, during
ILC lineage specification and at the transition of ILC2P to ILC2.
Altogether, our data demonstrate that, similar to the role of
RORgt for RORgt+ ILCs, GATA-3 is required for the ILC2 fate.
It is an emerging theme that the distinct ILC subsets use tran-
scriptional programs previously identified to be in control of
various Th cell effector fates. For example, RORgt is required
for both the Th17 cell program and the development and function
of RORgt+ ILCs. We have provided conclusive evidence that
another ILC subset resembling Th2 cells requires GATA-3 for
lineage specification and maintenance. These findings may
indicate that these transcriptional programs are conserved in
both the innate and adaptive arms of the immune system.
However, there are also obvious dissimilarities. Under steady-
state conditions, CD4+ T cells are naive cells that do not express
GATA-3 or RORgt before encountering their cognate antigen.
It is only upon TCR ligation that the small pool of antigen-
specific T cells expands and effector-fate determining transcrip-
tion factors are upregulated. In contrast, the ILC lineages
require RORgt or GATA-3 at the lineage specification stage in
primary lymphoid organs (fetal liver or bone marrow), unlikens at the day of infection (white bars) and at day 5 after N. brasiliensis infection.
ngs of the indicated mouse strains. Numbers in graph represent percentage of
(F) expression by intestinal epithelial cells isolated from the indicated treatment
te goblet cells with high amounts of mucus production. Scale bars represent
ms are electronically gated on LSIG cells or ILC2s. Open histograms represent
) and Ccr9-deficient (I, bottom) mice. Numbers represent percentage of cells in
ed organs of control (white bars) or Ccr9-deficient (black bars) mice.
, **p% 0.01. LSIG: LinSca1hiId2hiGATA-3hi bone marrow cells.
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Figure 7. GATA-3 Controls Cell Fate and Maintenance of ILC2s
(A) Analyses of RORgt and KLRG1 expression by YFP+ (Cre-on) and YFP (Cre-off) fractions of CD45+CD3CD19 lamina propria cells from the indicatedmouse
strains. Numbers represent percent cells in quadrant.
(B) GATA-3 expression by intestinal YFP+ (Cre-on) RORgt+ ILCs of Gata-3+/+ (gray) or Gata-3f/f (open) animals.
(C) Expression of GATA-3 and KLRG1 by YFP+ (Cre-on) and YFP (Cre-off) fractions of CD45+CD3CD19 intestinal lamina propria cells from the indicated
mouse strains. Numbers represent percent cells in gate.
(D and E) Percentage (±SD; n = 4) of KLRG1+YFP+ cells (D) and of YFP+ cells (E) among CD45+CD3CD19 lamina propria lymphocytes from the
indicated mice.
(F) Lamina propria lymphocytes from the indicated mouse strains were stimulated for 4 hr with PMA and ionomycin. IL-5 and IL-13 production was analyzed by
intracellular cytokine staining and flow cytometry analysis of electronically gated CD45+CD3CD19CD90+ lamina propria lymphocytes. Numbers indicate
percent cells in quadrant.
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GATA-3 and ILC2 FateT cells, which can, in general, develop in the absence of these
transcription factors. Such differences may well reflect the diver-
gent design principles of the innate and adaptive immune
systems.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 mice were purchased from Janvier. Information about the genetically
modified mouse strains used in this study can be found in the Supplemental
Experimental Procedures. Mice were kept under specific-pathogen-free
conditions and experiments were performed in accordance with the guidelines
of the animal care and use committees and the Regierungspra¨sidium Freiburg
and Erlangen.
Microarray Analysis
RNA for microarray was isolated with the RNeasy Micro Kit (QIAGEN) accord-
ing to the manufacturer’s protocol. RNA integrity was determined before
amplification with the Ovation Pico WTA V2 kit (Nugen). Amplified cDNA
samples were further fragmented and labeled with the Affymetrix WT labeling
kit. Labeled fragments were hybridized to GeneChip ST1.0 before analysis
with the Affymetrix GeneChip Scanner 3000 7G.
Cell Sorting and Adoptive Transfer Experiments
The indicated cell populations were isolated from the respective organs and
were highly purified (>98%) with a MoFlo Astrios cell sorter. Cells were trans-
ferred i.v. into nonirradiated Rag2/Il2rg/mice on a BALB/c background or
were used for in vitro experiments.
N. brasiliensis Infection
C57BL/6 Rag2/Il2rg/ mice were reconstituted with 1 3 104 LSIG cells.
Four weeks later, reconstituted mice were injected s.c. with 500 purified
N. brasiliensis stage 3 larvae (see also Supplemental Experimental Proce-
dures). Injection of IL-25 and IL-33 (250 ng/ml each; BioLegends) was per-
formed at day 0 and day 2 after infection and mice were sacrificed for analysis
at day 5 postinfection. During infection, mice were provided drinking water
supplemented with antibiotics (2 g/l neomycin sulfate, 100 mg/l polymixin B
sulfate; Sigma-Aldrich).
Histology
Ileal tissues were fixed in 4% paraformaldehyde and embedded in OCT
compound (Tissue-Tek) before freezing at 80C. Histological sections with
a thickness of 7 mm were stained with Alcian blue working solution for
15 min, followed by extensive washing, and were mounted with Aquatex
(Merck).
In Vitro Differentiation
The indicated, highly purified cell populations were seeded onto mitomycin
C-treated, mitotically inactivated OP9- or OP9Dll-1 feeder cells. Cytokines
were added to the culture at a concentration of 20 ng/ml if not indicated other-
wise. Clonal differentiation assays are described in detail in the Supplemental
Experimental Procedures.
Statistical Analysis
Significance level of the data sets was determined by performing a two-tailed
Student’s t test. If equal variances between the groups could not be assumed,
Welch’s correction of the t test was applied. Tests for statistical significance(G) Highly purified YFP ILC2s were cultured onmitotically inactivated OP9 feeder
analyzed for expression of YFP and KLRG1. Numbers represent percentage of c
(H) Expression of Sca1 and YFP among Lin cells of the bone marrow from the i
(I) Expression of CD25 and Sca1 by Lin bone marrow cells. Numbers indicate p
(Cre-on) in electronically gated LinCD25+Sca1hi bone marrow cells of the indica
(J) Highly purified YFP+ ILC2Ps were cultured on mitotically inactivated OP9 feede
were analyzed for expression of YFP and KLRG1. Numbers represent percentag
All data are representative of at least two independent experiments. ***p% 0.00were performed with Graph Pad Prism v4 software (*p < 0.05; **p < 0.01;
***p < 0.001; n.s., not significant).
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